INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 45h ago
HOUSE PTR5h ago
SEC 13F5h ago
ROBINHOOD CHAIN5h ago
Public company

CVCapsoVision, Inc

CIK 0001378325

EDGAR filingsOpen in network
Disclosed transactions33
Buys / sells1 / 0
Max Insider Score52
Connections10with evidence

CV · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
52
SH
Shen Ching Hang10% Owner
CVCapsoVision, Inc
Open-market purchase
BUY$5.00M
878.7K sh
Sep 15, 2026Sep 18, 2026
traded Sep 15, 2026
+3dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 3845 · Electromedical & Electrotherapeutic Apparatus · Nov 4, 2026
  • ← Insider ofevidence
    Shen Ching Hang10% Owner · Sep 18, 2026
  • ← Insider ofevidence
    Shields David StanleyDirector · Jul 2, 2026
  • ← Insider ofevidence
    Garcia David MichaelSr. VP of Finance · Jun 3, 2026
9
SS
Shields David StanleyDirector
CVCapsoVision, Inc
Grant or award
A
—
1,710 sh
Jul 1, 2026
Jul 2, 2026
traded Jul 1, 2026
+1d
SEC FORM 4

Evidence

13
KH
King Wen-Herng HenryDirector
CVCapsoVision, Inc
Option exercise
M$15K
2,022 sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC FORM 4

Evidence

21
KY
Kuo Hui YingDirector
CVCapsoVision, Inc
Option exercise
M—
2,022 sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC FORM 4

Evidence

13
KY
Kuo Hui YingDirector
CVCapsoVision, Inc
Option exercise
M$15K
2,022 sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC FORM 4

Evidence

21
IC
Imperial Joanne CarolDirector
CVCapsoVision, Inc
Option exercise
M—
2,022 sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC FORM 4

Evidence

21
IC
Imperial Joanne CarolDirector
CVCapsoVision, Inc
Option exercise
M$15K
2,022 sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC FORM 4

Evidence

21
HM
Harari MicheleDirector
CVCapsoVision, Inc
Option exercise
M—
2,022 sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC FORM 4

Evidence

21
KH
King Wen-Herng HenryDirector
CVCapsoVision, Inc
Option exercise
M—
2,022 sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC FORM 4

Evidence

9
HM
Harari MicheleDirector
CVCapsoVision, Inc
Option exercise
M$15K
2,022 sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC FORM 4

Evidence

21
WH
Wang Kang-HuaiDirector, See Remarks
CVCapsoVision, Inc
Grant or award
A—
358.3K sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC FORM 4

Evidence

21
AP
Atkinson Douglas PatrickHead of Global Sales
CVCapsoVision, Inc
Grant or award
A—
158.1K sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC FORM 4

Evidence

21
GM
Garcia David MichaelSr. VP of Finance
CVCapsoVision, Inc
Grant or award
A—
92.2K sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC FORM 4

Evidence

9
AP
Atkinson Douglas PatrickHead of Global Sales
CVCapsoVision, Inc
Option exercise
M—
36.0K sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC FORM 4

Evidence

9
AP
Atkinson Douglas PatrickHead of Global Sales
CVCapsoVision, Inc
Option exercise
M$10K
36.0K sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC FORM 4

Evidence

21
AP
Atkinson Douglas PatrickHead of Global Sales
CVCapsoVision, Inc
Option exercise
M$11K
30.0K sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC FORM 4

Evidence

13
AP
Atkinson Douglas PatrickHead of Global Sales
CVCapsoVision, Inc
Option exercise
M$3,682
6,505 sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC FORM 4

Evidence

17
AP
Atkinson Douglas PatrickHead of Global Sales
CVCapsoVision, Inc
Option exercise
M$20K
34.8K sh
May 5, 2026May 6, 2026
traded May 5, 2026
+1dSEC FORM 4

Evidence

9
AP
Atkinson Douglas PatrickHead of Global Sales
CVCapsoVision, Inc
Option exercise
M—
30.0K sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC FORM 4

Evidence

13
AP
Atkinson Douglas PatrickHead of Global Sales
CVCapsoVision, Inc
Option exercise
M—
6,505 sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC FORM 4

Evidence

9
AP
Atkinson Douglas PatrickHead of Global Sales
CVCapsoVision, Inc
Option exercise
M—
34.8K sh
May 5, 2026May 6, 2026
traded May 5, 2026
+1dSEC FORM 4

Evidence

9
HM
Harari MicheleDirector
CVCapsoVision, Inc
Grant or award
A—
4,045 sh
Mar 19, 2026Mar 23, 2026
traded Mar 19, 2026
+4dSEC FORM 4

Evidence

9
IC
Imperial Joanne CarolDirector
CVCapsoVision, Inc
Grant or award
A—
4,045 sh
Mar 19, 2026Mar 23, 2026
traded Mar 19, 2026
+4dSEC FORM 4

Evidence

9
KH
King Wen-Herng HenryDirector
CVCapsoVision, Inc
Grant or award
A—
4,045 sh
Mar 19, 2026Mar 23, 2026
traded Mar 19, 2026
+4dSEC FORM 4

Evidence

9
KY
Kuo Hui YingDirector
CVCapsoVision, Inc
Grant or award
A—
4,045 sh
Mar 19, 2026Mar 23, 2026
traded Mar 19, 2026
+4dSEC FORM 4

Evidence

9
KH
King Wen-Herng HenryDirector
CVCapsoVision, Inc
Option exercise
M—
2,887 sh
Dec 31, 2025Dec 31, 2025
traded Dec 31, 2025
+0dSEC FORM 4

Evidence

13
KH
King Wen-Herng HenryDirector
CVCapsoVision, Inc
Option exercise
M$31K
2,887 sh
Dec 31, 2025Dec 31, 2025
traded Dec 31, 2025
+0dSEC FORM 4

Evidence

9
KY
Kuo Hui YingDirector
CVCapsoVision, Inc
Option exercise
M—
2,887 sh
Dec 31, 2025Dec 31, 2025
traded Dec 31, 2025
+0dSEC FORM 4

Evidence

17
KY
Kuo Hui YingDirector
CVCapsoVision, Inc
Option exercise
M$31K
2,887 sh
Dec 31, 2025Dec 31, 2025
traded Dec 31, 2025
+0dSEC FORM 4

Evidence

9
IC
Imperial Joanne CarolDirector
CVCapsoVision, Inc
Option exercise
M—
2,887 sh
Dec 31, 2025Dec 31, 2025
traded Dec 31, 2025
+0dSEC FORM 4

Evidence

9
IC
Imperial Joanne CarolDirector
CVCapsoVision, Inc
Option exercise
M$31K
2,887 sh
Dec 31, 2025Dec 31, 2025
traded Dec 31, 2025
+0dSEC FORM 4

Evidence

9
HM
Harari MicheleDirector
CVCapsoVision, Inc
Option exercise
M—
2,887 sh
Dec 31, 2025Dec 31, 2025
traded Dec 31, 2025
+0dSEC FORM 4

Evidence

13
HM
Harari MicheleDirector
CVCapsoVision, Inc
Option exercise
M$31K
2,887 sh
Dec 31, 2025Dec 31, 2025
traded Dec 31, 2025
+0dSEC FORM 4

Evidence

  • ← Insider ofevidence
    Wang Kang-HuaiDirector, See Remarks · Jun 3, 2026
  • ← Insider ofevidence
    Atkinson Douglas PatrickHead of Global Sales · May 6, 2026
  • ← Insider ofevidence
    King Wen-Herng HenryDirector · Dec 31, 2025
  • ← Insider ofevidence
    Harari MicheleDirector · Dec 31, 2025
  • ← Insider ofevidence
    Imperial Joanne CarolDirector · Dec 31, 2025
  • ← Insider ofevidence
    Kuo Hui YingDirector · Dec 31, 2025